Aker BioMarine ASA (OSL:AKBM)

Market Cap	5.31B
Revenue (ttm)	2.12B
Net Income (ttm)	1.99B
Shares Out	87.70M
EPS (ttm)	22.69
PE Ratio	2.67
Forward PE	65.49
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,672
Average Volume	20,874
Open	62.00
Previous Close	61.40
Day's Range	59.70 - 62.30
52-Week Range	42.30 - 109.80
Beta	0.77
RSI	57.32
Earnings Date	Jul 11, 2025

About Aker BioMarine ASA

Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 249
• Stock Exchange: Oslo Børs
• Ticker Symbol: AKBM

Financial Performance

Financial numbers in USD